Advertisement

Product › Details
ProtEmbo® Cerebral Protection System
![]() |
Next higher product group | cardiovascular device_o |
![]() |
Status | 2017-05-12 development pp existent |
![]() |
Organisation | Protembis GmbH |
Record changed: 2024-07-31 |
Advertisement

More documents for cardiovascular device_o
- [1] CoreMedic GmbH. (1/10/25). "Press Release: CoreMedic Announces Partnership with InnoRa for Clinical Development of Transcatheter Mitral Valve Repair Device ChordArt". Basel & Philadelphia, PA....
- [2] Protembis GmbH. (7/30/24). "Press Release: German Medtech Protembis Gets €20 million EIB Backing for Technology to Protect Brain during Heart Treatment". Luxembourg & Aachen....
- [3] Protembis GmbH. (4/2/24). "Press Release: Protembis Announces First Patient Enrolled in the PROTEMBO IDE Pivotal Trial". New York, NY & Aachen....
- [4] Protembis GmbH. (3/26/24). "Press Release: Protembis Announces Completion of € 30 Million Series B Financing Round and the Addition of Keith D Dawkins MD to the Board of Directors". Aachen....
- [5] Royal Philips. (8/27/20). "Press Release: Philips to Expand Its Image-guided Therapy Devices Portfolio through Acquisition of Intact Vascular". Amsterdam....
- [6] CVRx, Inc.. (7/7/20). "Press Release: CVRx Raises $50 Million in New Equity Financing. Offering Will Support US Commercialization of Barostem Neo". Minneapolis, MN....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top